Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,028
Closed -$302K 246
2020
Q4
$302K Buy
1,028
+46
+5% +$11.8K 0.06% 217
2020
Q3
$232K Buy
+982
New +$223K 0.07% 177

Other funds holding AMED

Cooper Financial Group's AMED Position: Q1 2021 in Review

Cooper Financial Group sold out of Amedisys (AMED) in Q1 2021, closing a stake of 1,028 shares — an estimated $302K sold.

Cooper Financial Group first reported a position in AMED in Q3 2020 and held it in 2 quarters. The position peaked at $302K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Cooper Financial Group reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Cooper Financial Group sold 1,028 Amedisys shares in Q1 2021, an estimated $302K.
  • Cooper Financial Group first reported a position in Amedisys in Q3 2020 and held it in 2 quarters.
  • Cooper Financial Group's Amedisys position peaked at $302K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Cooper Financial Group's 13F filing for Q1 2021, filed 17 May 2021.